Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients
Use of recombinant human erythropoietin (rh-Epo) improves hemoglobin (Hgb) in 90-95% of the cases of anemia of chronic kidney disease (CKD). However, it is known that pro-inflammatory cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor-alfa (TNF-α) and interleukin-1 (IL-1) suppress ery...
Main Authors: | Amir-Hooshang Mohammadpour, Fatemeh Nazemian, Mohammad Hassanzade Khaiat, Mohsen Tafaghodi, Pooneh Salari, Somaieh Charkazi, Masih Naghibi, Jamal Shamsara |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2014;volume=25;issue=1;spage=73;epage=78;aulast=Mohammadpour |
Similar Items
-
Efeitos da pentoxifilina na anemia resistente à eritropoetina em pacientes sob hemodiálise Pentoxifylline effects on the resistant anemia to erythropoietin in hemodialysis patients
by: Sandra A. Antunes, et al.
Published: (2008-08-01) -
The effects of pentoxifylline administration on NFΚB P50 transcription factor expression
by: Jamal Shamsara, et al.
Published: (2011-12-01) -
Effects of omega-3 administration on homocysteine serum concentration in renal transplant recipient.
by: AmirHooshang Mohammadpour, et al.
Published: (2015-10-01) -
Recombinant human erythropoietin treatment of anemia in hemodialysis patients
by: Cinthya M. Ozawa, et al.
Published: (2007-05-01) -
Effectivity of Erythropoietin Alpha Compared to Erythropoietin Beta in Patients with Chronic Kidney Disease-Anemia on Hemodialysis
by: Anak Agung Ngurah Putra Riana Prasetya, et al.
Published: (2021-01-01)